Estrogen exerts an immunosuppressive effect on the tumor microenvironment, which can boost tolerance to weak immunogenic cancers; moreover, estrogen receptor (ER) can be expressed on most immunocytes, including macrophages, T and B lymphocytes, and NK cells [41]. This evidence concerns the gene ESR1 and cancer.